The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth-Reference-Cited by-同舟云学术

The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth

Published:2018-12-16 Issue:2 Volume:32 Page:303-314
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res

Author:

Cardoso Cibele¹²,Serafim Rodolfo B.¹,Kawakami Akinori²,Gonçalves Pereira Cristiano¹,Roszik Jason³,Valente Valeria¹⁴⁵,Vazquez Vinicius L.⁶,Fisher David E.²^ORCID,Espreafico Enilza M.¹^ORCID

Affiliation:

1. Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto University of São Paulo Ribeirão Preto Brazil

2. Cutaneous Biology Research Center, Department of Dermatology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts

3. Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

4. School of Pharmaceutical Sciences São Paulo State University (UNESP) Araraquara Brazil

5. Center for Cell‐Based Therapy CEPID/FAPESP Ribeirão Preto Brazil

6. Molecular Oncology Research Center (CPOM) and Melanoma/Sarcoma Surgery DepartmentBarretos Cancer Hospital Barretos Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

NIH Clinical Center

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.12751

Reference23 articles.

1. FOXD3 Is a Mutant B-RAF–Regulated Inhibitor of G1-S Progression in Melanoma Cells

2. Signatures of mutational processes in human cancer

3. Intergenic disease-associated regions are abundant in novel transcripts

4. An integrated encyclopedia of DNA elements in the human genome

5. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

2. Genomic Variants and Worldwide Epidemiology of Breast Cancer: A Genome-Wide Association Studies Correlation Analysis;Genes;2024-01-23

3. Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma;Biomedicines;2023-07-21

4. Long Noncoding RNAs in Human Cancer and Apoptosis;Current Pharmaceutical Biotechnology;2023-06

5. Long non-coding RNAs and melanoma: From diagnosis to therapy;Pathology - Research and Practice;2023-01